547 related articles for article (PubMed ID: 21987561)
1. [Progressive nonfluent aphasia].
Murayama S; Saito Y
Brain Nerve; 2011 Oct; 63(10):1037-46. PubMed ID: 21987561
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological correlations in behavioural variant frontotemporal dementia.
Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
[TBL] [Abstract][Full Text] [Related]
3. Frontotemporal lobar degeneration: diversity of FTLD lesions.
Seilhean D; Bielle F; Plu I; Duyckaerts C
Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
[TBL] [Abstract][Full Text] [Related]
5. [Clinical types of FTLD: progressive nonfluent aphasia; comparative discussions on the associated clinical presentations].
Fukui T
Brain Nerve; 2009 Nov; 61(11):1252-8. PubMed ID: 19938681
[TBL] [Abstract][Full Text] [Related]
6. [Neuropathology of frontotemporal dementia].
Murayama S
Rinsho Shinkeigaku; 2008 Nov; 48(11):998. PubMed ID: 19198143
[TBL] [Abstract][Full Text] [Related]
7. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
Mann DMA; Snowden JS
Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
[TBL] [Abstract][Full Text] [Related]
8. Progressive nonfluent aphasia: a rare clinical subtype of FTLD-TDP in Japan.
Aoki N; Tsuchiya K; Kobayashi Z; Arai T; Togo T; Miyazaki H; Kondo H; Ishizu H; Uchikado H; Katsuse O; Hirayasu Y; Akiyama H
Neuropathology; 2012 Jun; 32(3):272-9. PubMed ID: 21978320
[TBL] [Abstract][Full Text] [Related]
9. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.
Seltman RE; Matthews BR
CNS Drugs; 2012 Oct; 26(10):841-70. PubMed ID: 22950490
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pathology in primary progressive language and speech disorders.
Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F
Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
[TBL] [Abstract][Full Text] [Related]
12. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
Sha S; Hou C; Viskontas IV; Miller BL
Nat Clin Pract Neurol; 2006 Dec; 2(12):658-65. PubMed ID: 17117169
[TBL] [Abstract][Full Text] [Related]
13. [
Blazhenets G; Soleimani-Meigooni DN; Thomas W; Mundada N; Brendel M; Vento S; VandeVrede L; Heuer HW; Ljubenkov P; Rojas JC; Chen MK; Amuiri AN; Miller Z; Gorno-Tempini ML; Miller BL; Rosen HJ; Litvan I; Grossman M; Boeve B; Pantelyat A; Tartaglia MC; Irwin DJ; Dickerson BC; Baker SL; Boxer AL; Rabinovici GD; La Joie R
J Nucl Med; 2023 Dec; 64(12):1980-1989. PubMed ID: 37918868
[TBL] [Abstract][Full Text] [Related]
14. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
15. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
16. [Brain functional imaging of frontotemporal lobar degeneration].
Nakano S; Matsuda H
Brain Nerve; 2009 Nov; 61(11):1275-84. PubMed ID: 19938684
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.
Lladó A; Sánchez-Valle R; Rey MJ; Ezquerra M; Tolosa E; Ferrer I; Molinuevo JL;
J Neurol; 2008 Apr; 255(4):488-94. PubMed ID: 18357425
[TBL] [Abstract][Full Text] [Related]
18. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
[TBL] [Abstract][Full Text] [Related]
19. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.
Lleó A; Irwin DJ; Illán-Gala I; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
JAMA Neurol; 2018 Jun; 75(6):738-745. PubMed ID: 29554190
[TBL] [Abstract][Full Text] [Related]
20. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
